Tamoxifen for women at high risk of breast cancer

by Nazarali SA, Narod SA
Published 2014-02-01

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US

by McGrath LJ, Overman RA, Reams D, Cetin K, Liede A, Narod SA, Brookhart MA, Hernandez RK
Published 2018-09-01

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment

by Byrski T, Gronwald J, Huzarski T, Marczyk E, Blecharz P, Ashuryk O, Cybulski C, Zuziak D, Wiśniowski R, Godlewski D, Narod SA, Lubiński J
Published 2012-04-01

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?

by Byrski T, Huzarski T, Marczyk E, Blecharz P, Gronwald J, Ashuryk O, Cybulski C, Dębniak T, Zuziak D, Godlewski D, Kladny J, Lubinski J, Narod SA
Published 2012-01-01

Selenium and the risk of cancer in BRCA1 carriers

by Lubinski J, Jaworska K, Durda K, Jakubowska A, Huzarski T, Byrski T, Stawicka M, Gronwald J, Górski B, Wasowicz W, Kilar E, Szwiec M, Surdyka D, Marczyk E, Sun P, Narod SA
Published 2011-06-01

Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer

by Huzarski T T, Górecka-Szyld B, Huzarska J J, Psut G, Wilk G, Sibilski R, Cybulski C, Kozak-Klonowska B, Siołek M, Kilar E, Czudowska D, Janiszewska H, Godlewski D, Mackiewicz A, Jarkiewicz-Tretyn J, Szabo-Moskal I, Gronwald J, Lubiński J, Narod SA
Published 2012-12-01

Impact of BRCA1 mutation on survival after early onset breast cancer

by Huzarski T, Byrski T, Gronwald J, Górski B, Domagała W, Cybulski C, Sun Ping, Oszurek O, Szwiec M, Gugała K, Stawicka M, Morawiec Z, Mierzwa T, Janiszewska H, Kilar E, Marczyk E, Kozak-Klonowska B, Siołek M, Surdyka D, Wiśniowski R, Posmyk M, Lubiński J, Narod SA
Published 2012-12-01